Position in SVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$133,613,101
-$13,948,620 QoQ
Shares Held
24,471,264
0.0% QoQ
Ownership
11.9%
of shares outstanding
% of Portfolio
7.65%
of 13F equity value
Holder Rank
#1
of 184 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEA Management Company, LLC holds $1,651,836,644 across 23 Biotechnology names. SVRA ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
3,045,262 | $349,656,982 | |
| 2 | CELC |
Celcuity Inc.
|
2,285,561 | $260,873,932 | |
| 3 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $191,534,518 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $157,741,180 | |
| 5 | SVRA |
Savara Inc
This page
|
24,471,264 | $133,613,101 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $126,538,302 | |
| 7 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $107,892,407 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $78,653,931 |
All Filings in SVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133,613,101 | 24,471,264 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $147,561,721 | 24,471,264 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $87,362,412 | 24,471,264 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $55,794,481 | 24,471,264 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $67,785,401 | 24,471,264 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $75,126,780 | 24,471,264 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $103,758,159 | 24,471,264 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $98,619,193 | 24,471,264 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $121,866,894 | 24,471,264 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $115,014,940 | 24,471,264 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $92,501,377 | 24,471,264 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $77,120,689 | 24,137,931 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $47,068,965 | 24,137,931 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,413,793 | 24,137,931 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $37,413,793 | 24,137,931 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,689,655 | 24,137,931 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $31,620,689 | 24,137,931 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $29,931,034 | 24,137,931 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,310,344 | 24,137,931 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $41,034,482 | 24,137,931 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $50,206,896 | 24,137,931 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||